Home ›
Trademark Categories ›
Pharmaceuticals ›
2017 ›
CE ›
CELIXIR
Trademark search for:
CELIXIR
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2017-01-12 — Application filed
2017-04-27 — Sn assigned for sect 66a appl from ib
2017-05-01 — Application filed
2017-05-01 — Assigned to examiner
2017-05-05 — Application filed
2017-05-08 — Final disposition recorded
2017-05-09 — Office action issued
2017-05-16 — Office action issued
2017-05-16 — Office action issued
2017-06-03 — Office action issued
2017-07-25 — Office action issued
2017-07-25 — Correspondence received in law office
2017-07-26 — Teas/email correspondence entered
2017-08-04 — Teas change of correspondence received
2017-08-04 — Teas change of correspondence received
2017-08-17 — Office action issued
2017-08-17 — Office action issued
2017-08-17 — Office action issued
2017-11-14 — Examiners amendment -written
2017-11-14 — Examiners amendment e-mailed
2017-11-14 — Notification of examiners amendment e-mailed
2017-11-14 — Examiner's amendment entered
2017-11-16 — Approved for pub - principal register
2017-12-06 — Notice of start of opposition period created, to be sent to ib
2017-12-06 — Notification of notice of publication e-mailed
2017-12-06 — Notification of possible opposition sent to ib
2017-12-22 — Notification processed by ib
2017-12-26 — Published for opposition
2017-12-26 — Official gazette publication confirmation e-mailed
2018-03-13 — Registered-principal register
2018-06-13 — Final disposition recorded
2018-06-21 — Final disposition recorded
2018-06-21 — Final disposition recorded
2018-07-20 — Final disposition recorded
2019-10-25 — New representative at ib received
2021-12-04 — New representative at ib received
2023-03-13 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2024-09-27 — Cancelled section 71
2024-09-27 — Final status recorded
2025-05-27 — Total invalidation of reg ext protection created
2025-10-02 — Invalidation processed
2025-10-02 — Total invalidation of reg ext protection sent to ib
2025-10-24 — Total invalidation processed by the ib
Owner Information
Cell Therapy Limited
GB
Cell Therapy Limited
GB
Cell Therapy Limited
GB
Correspondent
Bess Morgan LOEB & LOEB LLP 10100 SANTA MONICA BLVD STE 2200 LOS ANGELES, CA 90067-4120 UNITED STATES
Filing Details
Filing Date:
2017-01-12
Status Date:
2024-09-27
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.